<DOC>
	<DOC>NCT00427635</DOC>
	<brief_summary>The purpose of this study is to assess the difference between esomeprazole and placebo in the treatment of signs and symptoms as observed by 8-hour video and cardiorespiratory monitoring in neonatal patients.</brief_summary>
	<brief_title>Efficacy and Safety of Esomeprazole Once Daily for the Treatment of GERD in Neonatal Patients</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Fullterm or gestational age &gt;/= 28 to 44 weeks Inpatient in Neonatal Intensive Care Unit, special care nursery, or equivalent Patient must be on a stable mode of feeding or with minimal variations for at least 2 days prior to randomization Patients with a need for resectional or reconstructive surgery of the gastrointestinal tract Patients with any condition that may require surgery during the course of the study Patients with acute respiratory distress within 72 hours prior to enrollment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>1 Month</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>neonates</keyword>
	<keyword>infants</keyword>
	<keyword>GERD</keyword>
	<keyword>reflux</keyword>
</DOC>